Incorporating immunotherapy in the management of early-stage estrogen receptor-positive breast cancer

Affiliations

• ¹ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA; Department of Medical Oncology, Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, USA; Department of Medical Oncology, Harvard Medical School, Boston, USA. Electronic address: guilherme_nadermarta@dfci.harvard.edu.
• ² Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA; Department of Medical Oncology, Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, USA; Department of Medical Oncology, Harvard Medical School, Boston, USA.